Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$723
|
$684B |
13.4x |
34.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$186
|
$393B |
6.8x |
15.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$154
|
$383B |
4.3x |
11.8x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 454
|
$315B |
6.8x |
13.8x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 262
|
$274B |
3.7x |
9.4x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 93
|
$244B |
4.5x |
11.0x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£104
|
$242B |
4.2x |
12.2x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$76
|
$217B |
3.4x |
7.9x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$284
|
$201B |
5.9x |
10.5x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$177B |
2.8x |
7.3x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$111
|
$155B |
5.4x |
12.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€93
|
$142B |
2.8x |
9.5x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$48
|
$137B |
2.9x |
12.1x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$447
|
$110B |
9.7x |
40.4x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$97.5B |
2.3x |
6.6x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 248
|
$87.5B |
5.7x |
16.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$167
|
$79.4B |
8.5x |
19.8x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7600
|
$79.3B |
9.7x |
19.6x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4252
|
$73.8B |
2.3x |
9.0x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€115
|
$64.3B |
2.7x |
9.4x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€25
|
$63.9B |
1.2x |
5.8x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 561
|
$52.7B |
6.3x |
22.0x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 54
|
$46.2B |
11.4x |
44.8x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3894
|
$45.5B |
3.5x |
17.0x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1700
|
$44.9B |
7.2x |
25.3x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$35.7B |
2.1x |
7.2x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 158700
|
$26.0B |
9.2x |
30.7x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 40
|
$24.5B |
2.2x |
11.0x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.8B |
1.7x |
5.4x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6881
|
$23.7B |
1.5x |
6.4x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$23.5B |
2.5x |
7.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 6
|
$22.0B |
2.2x |
6.4x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1414
|
$21.6B |
1.6x |
8.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$33
|
$19.6B |
6.8x |
7.3x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$16.8B |
2.0x |
8.2x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 26
|
$16.5B |
9.4x |
25.2x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 286
|
$15.8B |
26.3x |
52.8x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$14.3B |
5.1x |
13.9x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3161
|
$12.8B |
9.3x |
28.6x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 334500
|
$12.7B |
117.4x |
280.5x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1477
|
$12.7B |
3.9x |
15.2x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2466
|
$12.6B |
8.5x |
33.8x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 62
|
$12.3B |
8.6x |
280.9x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.1B |
2.1x |
15.4x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1248
|
$12.0B |
3.1x |
11.6x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 294
|
$11.7B |
4.2x |
11.6x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$124
|
$11.7B |
4.7x |
18.7x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 22
|
$10.9B |
1.9x |
11.3x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$10.9B |
1.7x |
5.6x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1969
|
$10.6B |
3.9x |
16.6x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 43
|
$10.4B |
1.7x |
13.7x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 925
|
$10.3B |
3.7x |
12.7x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.0B |
2.5x |
10.1x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1379
|
$9.7B |
2.9x |
8.3x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2388
|
$9.7B |
3.2x |
7.8x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 87
|
$9.5B |
25.0x |
-761.5x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 4
|
$9.4B |
2.3x |
9.9x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 22
|
$9.3B |
3.0x |
7.3x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€103
|
$9.3B |
2.3x |
6.5x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€58
|
$9.2B |
5.2x |
15.6x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 307
|
$8.5B |
31.8x |
-249.7x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1173
|
$8.0B |
2.1x |
10.1x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$7.5B |
0.2x |
3.5x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$55
|
$7.5B |
6.8x |
10.6x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£21
|
$7.4B |
2.2x |
8.6x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4042
|
$7.3B |
1.3x |
11.1x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 30337
|
$7.2B |
9.5x |
35.4x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 35
|
$7.1B |
N/A |
N/A |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5295
|
$7.0B |
4.5x |
22.9x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 43
|
$6.8B |
1.7x |
9.0x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2260
|
$6.6B |
2.0x |
8.5x |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 172
|
$6.6B |
14.9x |
20.3x |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 336
|
$6.3B |
3.4x |
16.4x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€123
|
$6.2B |
N/A |
N/A |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3269
|
$6.2B |
13.9x |
44.3x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 105288
|
$5.7B |
3.7x |
57.1x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$5.7B |
4.8x |
13.3x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€183
|
$5.7B |
2.6x |
9.6x |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 40
|
$5.7B |
8.8x |
30.1x |
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 20
|
$5.6B |
3.8x |
8.8x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 105
|
$5.3B |
2.8x |
11.1x |
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 37
|
$5.0B |
N/A |
N/A |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 19
|
$5.0B |
5.7x |
13.0x |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 500
|
$4.8B |
11.9x |
38.5x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.8B |
1.7x |
7.5x |
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10450
|
$4.8B |
1.9x |
5.2x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$20
|
$4.7B |
10.3x |
24.3x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1397
|
$4.7B |
3.0x |
16.5x |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 121
|
$4.6B |
1.9x |
8.3x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$4.6B |
8.2x |
28.9x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1545
|
$4.5B |
1.4x |
5.8x |
Amoytop Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 81
|
$4.5B |
10.0x |
26.6x |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 51
|
$4.4B |
5.8x |
20.1x |
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 58
|
$4.3B |
15.8x |
-34.6x |
Gan & Lee Pharmaceuticals
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 55
|
$4.3B |
8.6x |
33.8x |
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 261
|
$4.2B |
10.3x |
32.7x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$4.2B |
2.8x |
10.6x |
Hypera
|
Brazil |
Biopharmaceuticals,
Drug Development & Therapeutics
|
BRL 25
|
$4.2B |
3.0x |
11.0x |
Kalbe Farma
|
Indonesia |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
IDR 1515
|
$4.1B |
2.0x |
13.3x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 33
|
$4.1B |
13.2x |
-38.3x |